Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 1
2021 2
2022 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer.
D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W, Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schröder W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U Jr, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE; International Esodata Study Group. D'Journo XB, et al. JAMA Surg. 2021 Sep 1;156(9):836-845. doi: 10.1001/jamasurg.2021.2376. JAMA Surg. 2021. PMID: 34160587 Free PMC article. Clinical Trial.
Machine Learning Risk Prediction Model of 90-day Mortality After Gastrectomy for Cancer.
Pera M, Gibert J, Gimeno M, Garsot E, Eizaguirre E, Miró M, Castro S, Miranda C, Reka L, Leturio S, González-Duaigües M, Codony C, Gobbini Y, Luna A, Fernández-Ananín S, Sarriugarte A, Olona C, Rodríguez-Santiago J, Osorio J, Grande L; Spanish EURECCA Esophagogastric Cancer Group. Pera M, et al. Among authors: gimeno m. Ann Surg. 2022 Nov 1;276(5):776-783. doi: 10.1097/SLA.0000000000005616. Epub 2022 Jul 22. Ann Surg. 2022. PMID: 35866643
Continuous monitoring of adverse effects improves surgical outcomes.
Grande L, Gimeno M, Jimeno J, Pera M, Sancho-Insenser J, Pera M. Grande L, et al. Among authors: gimeno m. Cir Esp (Engl Ed). 2024 Apr;102(4):209-215. doi: 10.1016/j.cireng.2023.11.024. Epub 2024 Feb 9. Cir Esp (Engl Ed). 2024. PMID: 38342137
Textbook outcome and survival after gastric cancer resection with curative intent: A population-based analysis.
Dal Cero M, Román M, Grande L, Yarnoz C, Estremiana F, Gantxegi A, Codony C, Gobbini Y, Garsot E, Momblan D, González-Duaigües M, Luna A, Pérez N, Aldeano A, Fernández S, Olona C, Hermoso J, Pulido L, Sánchez-Cano JJ, Güell M, Salazar D, Gimeno M, Pera M; Spanish EURECCA Esophagogastric Cancer Group. Dal Cero M, et al. Among authors: gimeno m. Eur J Surg Oncol. 2022 Apr;48(4):768-775. doi: 10.1016/j.ejso.2021.10.025. Epub 2021 Nov 2. Eur J Surg Oncol. 2022. PMID: 34753620
Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy.
Gómez-Álvarez J, Martín Pastor S, Gimeno M, Lamo-Espinosa J, Ramos LI, Cambeiro M, Tagliaferri L, Kovacs G, Strnad V, San-Julián M, Martinez-Monge R. Gómez-Álvarez J, et al. Among authors: gimeno m. Radiother Oncol. 2022 May;170:159-164. doi: 10.1016/j.radonc.2022.02.025. Epub 2022 Feb 25. Radiother Oncol. 2022. PMID: 35227732 Free article.
Effect of Perioperative Blood Transfusions and Infectious Complications on Inflammatory Activation and Long-Term Survival Following Gastric Cancer Resection.
Puértolas N, Osorio J, Jericó C, Miranda C, Santamaría M, Artigau E, Galofré G, Garsot E, Luna A, Aldeano A, Olona C, Molinas J, Pulido L, Gimeno M, Pera M. Puértolas N, et al. Among authors: gimeno m. Cancers (Basel). 2022 Dec 26;15(1):144. doi: 10.3390/cancers15010144. Cancers (Basel). 2022. PMID: 36612141 Free PMC article.
Outcomes after totally minimally invasive versus hybrid and open Ivor Lewis oesophagectomy: results from the International Esodata Study Group.
van der Wilk BJ, Hagens ERC, Eyck BM, Gisbertz SS, van Hillegersberg R, Nafteux P, Schröder W, Nilsson M, Wijnhoven BPL, Lagarde SM, van Berge Henegouwen MI; International Esodata Study Group Collaborators. van der Wilk BJ, et al. Br J Surg. 2022 Feb 24;109(3):283-290. doi: 10.1093/bjs/znab432. Br J Surg. 2022. PMID: 35024794 Free PMC article.
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial.
Martínez-Monge R, Valtueña Peydró G, Cambeiro M, Aramendía JM, Gimeno M, Santisteban M, Lecanda F, Minguez JA, Alcázar JL, Jurado M. Martínez-Monge R, et al. Among authors: gimeno m. Brachytherapy. 2018 Sep-Oct;17(5):734-741. doi: 10.1016/j.brachy.2018.04.007. Epub 2018 May 24. Brachytherapy. 2018. PMID: 29803537 Clinical Trial.
Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study.
Gimeno M, San Julián M, Cambeiro M, Arbea L, Jablonska P, Moreno-Jiménez M, Amillo S, Aristu J, Lecanda F, Martinez-Monge R. Gimeno M, et al. Radiother Oncol. 2019 Jun;135:91-99. doi: 10.1016/j.radonc.2019.02.011. Epub 2019 Mar 19. Radiother Oncol. 2019. PMID: 31015176
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial.
Martínez-Monge R, Valtueña Peydró G, Cambeiro M, Aramendía JM, Gimeno M, Santisteban M, Lecanda F, Minguez JA, Alcázar JL, Jurado M. Martínez-Monge R, et al. Among authors: gimeno m. Brachytherapy. 2018 Nov-Dec;17(6):1045. doi: 10.1016/j.brachy.2018.09.001. Brachytherapy. 2018. PMID: 30415833 No abstract available.